Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2115)
All Articles published online
|
Publishing Process of This Article
|
May 27, 2024 (publication date) through Jan 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vij M, Veerankutty FH, Rammohan A, Rela M. Combined hepatocellular cholangiocarcinoma: A clinicopathological update. World J Hepatol 2024; 16(5): 766-775 [PMID: 38818284 DOI: 10.4254/wjh.v16.i5.766] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i5/766.htm |
| Number | Citing Articles |
| 1 |
Guo-qian He, Qing Li, Xiao-yu Jing, Jian Li, Ju Gao, Xia Guo. Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02190-w
|
| 2 |
Yue Li, Du He, Zi-Jian Lu, Xia-Fei Gu, Xiao-Yu Liu, Min Chen, Yin-Xia Tu, Yu Zhou, Gemma Owen, Xian Zhang, Dan Jiang. Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12970-8
|
| 3 |
Gilton Marques Fonseca, Paulo Herman. Reply to “Comment on ‘Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study’”. Journal of Surgical Oncology 2024; doi: 10.1002/jso.28056
|